Burns. Infection and immunology. 1985

A M Munster, and R A Winchurch
Baltimore Regional Burn Center, Johns Hopkins University, Maryland.

The burn wound is successively colonized by gram-positive then gram-negative flora. The reduction of mortality from sepsis in burns depends on our understanding of the chain of events leading to microbial invasion of the burn wound and the host response that follows. These are outlined in this article, together with the current attempts to improve this response in the host.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D014946 Wound Infection Invasion of a wound by pathogenic microorganisms. Infection, Wound,Infections, Wound,Wound Infections

Related Publications

A M Munster, and R A Winchurch
January 1987, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
A M Munster, and R A Winchurch
May 1978, Ugeskrift for laeger,
A M Munster, and R A Winchurch
September 1987, Seminars in adolescent medicine,
A M Munster, and R A Winchurch
January 1985, The Journal of burn care & rehabilitation,
A M Munster, and R A Winchurch
April 1975, Lakartidningen,
A M Munster, and R A Winchurch
January 1993, Journal of acquired immune deficiency syndromes,
A M Munster, and R A Winchurch
December 1973, Khirurgiia,
A M Munster, and R A Winchurch
April 1954, Proceedings of the Royal Society of Medicine,
A M Munster, and R A Winchurch
April 1960, British medical journal,
A M Munster, and R A Winchurch
April 2016, Surgical infections,
Copied contents to your clipboard!